Computer-aided design of a novel ligand for retinoic acid receptor in cancer chemotherapy
Nenhuma Miniatura disponível
Data
2005-05-05
Autores
Silva, CHTP
Leopoldino, A. M.
Silva, EHT
Espinoza, VAA
Taft, C. A.
Título da Revista
ISSN da Revista
Título de Volume
Editor
Wiley-Blackwell
Resumo
The isotypes of RAR and RXR are retinoic acid and retinoid X acid receptors, respectively, whose ligand-binding domain contains the ligand-dependent activation function, with distinct pharmacological targets for retinoids, involved in the treatment of various cancers and skin diseases. Due to the major challenge which cancer treatment and cure still imposes after many decades to the international scientific community, there is actually considerable interest in new ligands with increased bioactivity. We have focused on the retinoid acid receptor, which is considered an interesting target for drug design. In this work, we carried out density functional geometry optimizations, and different docking procedures. We performed screening in a large database (hundreds of thousands of molecules which we optimized at the AM1 level) yielding a set of potential bioactive ligands. A new ligand was selected and optimized at the B3LYP/6-31G* level. A flexible docking program was used to investigate the interactions between the receptor and the new ligand. The result of this work is compared with several crystallographic ligands of RAR. Our theoretically more bioactive new-ligand indicates stronger and more hydrogen bonds as well as hydrophobic interactions with the receptor. (c) 2005 Wiley Periodicals, Inc.
Descrição
Palavras-chave
Câncer, retinoic acid receptor, functional density
Como citar
International Journal of Quantum Chemistry. Hoboken: John Wiley & Sons Inc., v. 102, n. 6, p. 1131-1135, 2005.